Logo image of NCLH

NORWEGIAN CRUISE LINE HOLDIN (NCLH) Stock Fundamental Analysis

NYSE:NCLH - BMG667211046 - Common Stock

25.05 USD
+1.69 (+7.23%)
Last: 8/22/2025, 10:21:54 PM
25.03 USD
-0.02 (-0.08%)
After Hours: 8/22/2025, 10:21:54 PM
Fundamental Rating

3

Taking everything into account, NCLH scores 3 out of 10 in our fundamental rating. NCLH was compared to 131 industry peers in the Hotels, Restaurants & Leisure industry. There are concerns on the financial health of NCLH while its profitability can be described as average. NCLH has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year NCLH was profitable.
NCLH had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: NCLH reported negative net income in multiple years.
In multiple years NCLH reported negative operating cash flow during the last 5 years.
NCLH Yearly Net Income VS EBIT VS OCF VS FCFNCLH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B -2B -4B

1.2 Ratios

NCLH has a Return On Assets (3.33%) which is in line with its industry peers.
NCLH has a better Return On Equity (45.82%) than 93.13% of its industry peers.
Looking at the Return On Invested Capital, with a value of 7.95%, NCLH is in the better half of the industry, outperforming 64.12% of the companies in the same industry.
Industry RankSector Rank
ROA 3.33%
ROE 45.82%
ROIC 7.95%
ROA(3y)-2.27%
ROA(5y)-10.54%
ROE(3y)-1056.87%
ROE(5y)-689.6%
ROIC(3y)N/A
ROIC(5y)N/A
NCLH Yearly ROA, ROE, ROICNCLH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -1K -2K -3K

1.3 Margins

NCLH has a Profit Margin of 7.52%. This is in the better half of the industry: NCLH outperforms 64.12% of its industry peers.
In the last couple of years the Profit Margin of NCLH has declined.
The Operating Margin of NCLH (16.01%) is better than 69.47% of its industry peers.
In the last couple of years the Operating Margin of NCLH has declined.
NCLH has a worse Gross Margin (41.35%) than 61.07% of its industry peers.
NCLH's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 16.01%
PM (TTM) 7.52%
GM 41.35%
OM growth 3YN/A
OM growth 5Y-3.24%
PM growth 3YN/A
PM growth 5Y-7.78%
GM growth 3YN/A
GM growth 5Y-1.58%
NCLH Yearly Profit, Operating, Gross MarginsNCLH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200 -400 -600

0

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), NCLH is destroying value.
Compared to 1 year ago, NCLH has more shares outstanding
The number of shares outstanding for NCLH has been increased compared to 5 years ago.
The debt/assets ratio for NCLH has been reduced compared to a year ago.
NCLH Yearly Shares OutstandingNCLH Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M
NCLH Yearly Total Debt VS Total AssetsNCLH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.2 Solvency

Based on the Altman-Z score of 0.34, we must say that NCLH is in the distress zone and has some risk of bankruptcy.
NCLH has a Altman-Z score of 0.34. This is amonst the worse of the industry: NCLH underperforms 80.15% of its industry peers.
A Debt/Equity ratio of 8.05 is on the high side and indicates that NCLH has dependencies on debt financing.
Looking at the Debt to Equity ratio, with a value of 8.05, NCLH is doing worse than 65.65% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 8.05
Debt/FCF N/A
Altman-Z 0.34
ROIC/WACC0.92
WACC8.65%
NCLH Yearly LT Debt VS Equity VS FCFNCLH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B 10B

2.3 Liquidity

NCLH has a Current Ratio of 0.18. This is a bad value and indicates that NCLH is not financially healthy enough and could expect problems in meeting its short term obligations.
The Current ratio of NCLH (0.18) is worse than 97.71% of its industry peers.
NCLH has a Quick Ratio of 0.18. This is a bad value and indicates that NCLH is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.16, NCLH is doing worse than 96.95% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.18
Quick Ratio 0.16
NCLH Yearly Current Assets VS Current LiabilitesNCLH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

5

3. Growth

3.1 Past

NCLH shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 60.53%, which is quite impressive.
Measured over the past years, NCLH shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -18.68% on average per year.
Looking at the last year, NCLH shows a small growth in Revenue. The Revenue has grown by 5.23% in the last year.
The Revenue has been growing slightly by 7.96% on average over the past years.
EPS 1Y (TTM)60.53%
EPS 3YN/A
EPS 5Y-18.68%
EPS Q2Q%27.5%
Revenue 1Y (TTM)5.23%
Revenue growth 3Y144.57%
Revenue growth 5Y7.96%
Sales Q2Q%6.11%

3.2 Future

Based on estimates for the next years, NCLH will show a quite strong growth in Earnings Per Share. The EPS will grow by 17.36% on average per year.
The Revenue is expected to grow by 7.78% on average over the next years.
EPS Next Y14.86%
EPS Next 2Y19.63%
EPS Next 3Y19.18%
EPS Next 5Y17.36%
Revenue Next Year6.08%
Revenue Next 2Y8.23%
Revenue Next 3Y8.28%
Revenue Next 5Y7.78%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
NCLH Yearly Revenue VS EstimatesNCLH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 5B 10B 15B
NCLH Yearly EPS VS EstimatesNCLH Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 0 5 -5

5

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 13.69, which indicates a correct valuation of NCLH.
Compared to the rest of the industry, the Price/Earnings ratio of NCLH indicates a rather cheap valuation: NCLH is cheaper than 87.02% of the companies listed in the same industry.
The average S&P500 Price/Earnings ratio is at 27.24. NCLH is valued slightly cheaper when compared to this.
A Price/Forward Earnings ratio of 9.67 indicates a reasonable valuation of NCLH.
Compared to the rest of the industry, the Price/Forward Earnings ratio of NCLH indicates a rather cheap valuation: NCLH is cheaper than 91.60% of the companies listed in the same industry.
NCLH's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 22.81.
Industry RankSector Rank
PE 13.69
Fwd PE 9.67
NCLH Price Earnings VS Forward Price EarningsNCLH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80 100

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of NCLH indicates a somewhat cheap valuation: NCLH is cheaper than 70.99% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 9.84
NCLH Per share dataNCLH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20

4.3 Compensation for Growth

NCLH's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as NCLH's earnings are expected to grow with 19.18% in the coming years.
PEG (NY)0.92
PEG (5Y)N/A
EPS Next 2Y19.63%
EPS Next 3Y19.18%

0

5. Dividend

5.1 Amount

NCLH does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

NORWEGIAN CRUISE LINE HOLDIN

NYSE:NCLH (8/22/2025, 10:21:54 PM)

After market: 25.03 -0.02 (-0.08%)

25.05

+1.69 (+7.23%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)07-31 2025-07-31/bmo
Earnings (Next)10-29 2025-10-29/bmo
Inst Owners80.84%
Inst Owner Change0.23%
Ins Owners0.35%
Ins Owner Change1.28%
Market Cap11.32B
Analysts80
Price Target30.29 (20.92%)
Short Float %5.92%
Short Ratio1.74
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-13.74%
Min EPS beat(2)-24.41%
Max EPS beat(2)-3.06%
EPS beat(4)2
Avg EPS beat(4)29.42%
Min EPS beat(4)-24.41%
Max EPS beat(4)142.19%
EPS beat(8)5
Avg EPS beat(8)18.33%
EPS beat(12)8
Avg EPS beat(12)14.68%
EPS beat(16)8
Avg EPS beat(16)6.75%
Revenue beat(2)0
Avg Revenue beat(2)-3.08%
Min Revenue beat(2)-3.4%
Max Revenue beat(2)-2.76%
Revenue beat(4)0
Avg Revenue beat(4)-2.15%
Min Revenue beat(4)-3.4%
Max Revenue beat(4)-0.69%
Revenue beat(8)0
Avg Revenue beat(8)-2.26%
Revenue beat(12)1
Avg Revenue beat(12)-1.42%
Revenue beat(16)1
Avg Revenue beat(16)-6.02%
PT rev (1m)16.96%
PT rev (3m)17.65%
EPS NQ rev (1m)-1.05%
EPS NQ rev (3m)-5.4%
EPS NY rev (1m)0.54%
EPS NY rev (3m)-0.01%
Revenue NQ rev (1m)-0.52%
Revenue NQ rev (3m)-2.78%
Revenue NY rev (1m)-0.4%
Revenue NY rev (3m)-0.44%
Valuation
Industry RankSector Rank
PE 13.69
Fwd PE 9.67
P/S 1.18
P/FCF N/A
P/OCF 5.76
P/B 7.21
P/tB 12.13
EV/EBITDA 9.84
EPS(TTM)1.83
EY7.31%
EPS(NY)2.59
Fwd EY10.34%
FCF(TTM)-1.12
FCFYN/A
OCF(TTM)4.35
OCFY17.36%
SpS21.16
BVpS3.47
TBVpS2.07
PEG (NY)0.92
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 3.33%
ROE 45.82%
ROCE 10.07%
ROIC 7.95%
ROICexc 8.05%
ROICexgc 8.4%
OM 16.01%
PM (TTM) 7.52%
GM 41.35%
FCFM N/A
ROA(3y)-2.27%
ROA(5y)-10.54%
ROE(3y)-1056.87%
ROE(5y)-689.6%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y-0.2%
ROICexc growth 3YN/A
ROICexc growth 5Y2.69%
OM growth 3YN/A
OM growth 5Y-3.24%
PM growth 3YN/A
PM growth 5Y-7.78%
GM growth 3YN/A
GM growth 5Y-1.58%
F-Score6
Asset Turnover0.44
Health
Industry RankSector Rank
Debt/Equity 8.05
Debt/FCF N/A
Debt/EBITDA 4.99
Cap/Depr 246.92%
Cap/Sales 25.84%
Interest Coverage 250
Cash Conversion 77.66%
Profit Quality N/A
Current Ratio 0.18
Quick Ratio 0.16
Altman-Z 0.34
F-Score6
WACC8.65%
ROIC/WACC0.92
Cap/Depr(3y)218.66%
Cap/Depr(5y)176.64%
Cap/Sales(3y)27.26%
Cap/Sales(5y)54.38%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)60.53%
EPS 3YN/A
EPS 5Y-18.68%
EPS Q2Q%27.5%
EPS Next Y14.86%
EPS Next 2Y19.63%
EPS Next 3Y19.18%
EPS Next 5Y17.36%
Revenue 1Y (TTM)5.23%
Revenue growth 3Y144.57%
Revenue growth 5Y7.96%
Sales Q2Q%6.11%
Revenue Next Year6.08%
Revenue Next 2Y8.23%
Revenue Next 3Y8.28%
Revenue Next 5Y7.78%
EBIT growth 1Y26.76%
EBIT growth 3YN/A
EBIT growth 5Y4.47%
EBIT Next Year80.23%
EBIT Next 3Y31.66%
EBIT Next 5Y21.72%
FCF growth 1Y12.48%
FCF growth 3YN/A
FCF growth 5Y35.24%
OCF growth 1Y5.95%
OCF growth 3YN/A
OCF growth 5Y2.38%